Cited by 377Antifungal resistance and susceptibilityFungal Infections and StudiesFungal Plant Pathogen Control

The DOI matches its Crossref record; 922 of the 930 references it cites were found in a registry or an index.

Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development

Groll, Andreas H., Piscitelli, Stephen C., Walsh, Thomas J.·1998·Advances in pharmacology

DOI 10.1016/s1054-3589(08)60129-5

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s1054-3589(08)60129-5

Cites

922 of 922 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,045
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
POLYAMINES
Tabor, C. W., & Tabor, H. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.003533 · Cited by 3,111
DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
Liu, L. F. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002031 · Cited by 1,805
Cell Wall Chemistry, Morphogenesis, and Taxonomy of Fungi
Bartnicki-García, S. (1968) · Annual Review of Microbiology · doi:10.1146/annurev.mi.22.100168.000511 · Cited by 1,569
A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B. C., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P. J., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,164
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Peptide antibiotics
Hancock, R. E. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,098

Show all 930 references

Research works printed but not linked: 18

Atkinson, 1969, Pharmacokinetics of intrathecal administered amphotericin B., Am. Rev. Respir. Dis., 99, 917
Benhamu, 1991, Does ketoconazole prevent fungal infection in children treated with high-dose chemotherapy and bone-marrow transplantation?, Bone Marrow Transplant., 7, 127
Bernardo, 1994, The effect of L-arginine on amphotericin B-induced nephrotoxicity., J. Am. Soc. Nephrol., 5, 917
Brammer, 1987, A review of the pharmacokinetics of fluconazole (UK-49,858) in laboratory animals and man, 141
Feldman, 1992, The use of granulocyte-stimulating factor (GCSF) enhanced granulocyte transfusions from normal donors in patients with neutropenia related fungal infections, Blood, 80, 414a
G. Gaenger, G. Just-Nuebling, M. Eichel, R. Hoika, W. Stille (1993). Itraconazole solution in patients with non-response to fluconazole. In Abstracts of the IXth International Conference on AIDS, abstract 1394.
Gascoigne, 1981, The kinetics of ketoconazole in animals and man., Clin. Res. Rev., 1, 177
Gelfand, 1988, Amphotericin B treatment of human mononuclear cells in vitro results in secretion of tumor necrosis factor and interleukin-1., Clin. Res., 36, 456
Graybill, 1982, Ketoconazole therapy for systemic fungal infections: Inadequacy of standard dose regimens., Am. Rev. Respir. Dis., 126, 171
Gupta, 1994, Antifungal agents: An overview. Part II., J. Am. Acad. Dermatol., 30, 911, 10.1016/S0190-9622(94)70112-1 · DOI
Hiemenz, 1995, Emergency use of amphotericin B lipid complex (ABLC) in the treatment of patients with aspergillosis historical control comparison with amphotericin B, Blood, 86, 849a
Jolidon, 1993, 2,3 oxidosqualene-lanosterol cyclase, an attractive target for antifungal drug design.
Moore, 1995, Hematopoietic reconstitution: New approaches., Clin. Cancer Res., 1, 3
Peeters, 1986, Itraconzole, a new orally active triazole derivative for treatment of vaginal candidosis., Curr. Ther. Res., 39, 496
Plempel, 1988, Antimycotic effects of BAY R 3783 in vitro and on dermatophytoses and opportunistic mycoses of the organs in vivo, Rev. lb. Micol., 5, 0
Ringden, 1993, Clinical experience with AmBisome with special emphasis on experience with children., Bone Marrow Transplant., 12, S149
Schaude, 1988, Biological activity of SDZ 89485 in animal models., Rev. lb. Micol., 5, P51
Shepard, 1986, Cyclosporin-ketoconazole: A potentially dangerous drug interaction., Clin. Pharmacol., 6, 468

Sorted by citations

Items 201–300 of 377

Inhibitors of Civ1 kinase belonging to 6-aminoaromatic-2-cyclohexyldiamino purine series as potent anti-fungal compounds
Bordon, F., Jullian, N., Ferrari, P., Girard, A.-M., Bocquel, M. T., Biton, J., Bouquin, N., & Haesslein, J. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.025 · Cited by 16
Pd@Ag Nanosheets in Combination with Amphotericin B Exert a Potent Anti-Cryptococcal Fungicidal Effect
Zhang, C., Chen, M., Wang, G., Fang, W. Y., Ye, C., Hu, H., Fa, Z., Yi, J., & Liao, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157000 · Cited by 16
A simple one-pot method for the mercuric oxide mediated synthesis of piperazines via oxidative diamination of olefins
Kour, H., Paul, S., Singh, P. P., Gupta, M., & Gupta, R. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.11.110 · Cited by 16
AmBisome® Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies
Zuccari, G., Villa, C., Iurilli, V., Barabino, P., Zorzoli, A., Marimpietri, D., Caviglia, D., & Russo, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040466 · Cited by 15
Guías de práctica clínica para el manejo de la candidiasis: actualización del 2009, de la Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D. R., Benjamin, D. K., Calandra, T., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B. J., Ostrosky-Zeichner, L. L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598961 · Cited by 16
Antifungal Use in Veterinary Practice and Emergence of Resistance
Seyedmousavi, S., Wiederhold, N. P., Ebel, F., Hedayati, M. T., Rafati, H., & Verweij, P. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-72093-7_16 · Cited by 15
Cryptococcal disease and HIV infection
Waters, L. J., & Nelson, M. R. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.15.2633 · Cited by 15
Studies Regarding the Antimicrobial Behavior of Clotrimazole and Limonene
Schröder, V., Radu, N., Cornea, P. C., Coman, O. A., Pirvu, L. C., Mohammed, M. S. O., Ștefaniu, A., Pintilie, L., Bostan, M., Caramihai, M. D., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11121816 · Cited by 14
Influence of the papiliocin peptide derived from Papilio xuthus on the perturbation of fungal cell membranes
Lee, J., Hwang, J., Hwang, B., Kim, J., Kim, S., Kim, Y., & Lee, D. G. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02073.x · Cited by 14
In vitro susceptibility of dermatophytes isolated from patients with end‐stage renal disease: a case–control study
Irimie, M., Tataru, A. D., Oanţă, A., & Moga, M. (2013) · Mycoses · doi:10.1111/myc.12114 · Cited by 14
Transferosomes as innovative drug delivery systems for enhanced antifungal therapy: A comprehensive review
Chamel, S., Mishra, A., & Gull, A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105545 · Cited by 15
Design, synthesis and antifungal activity of novel selenochroman-4-one derivatives
Xu, H., Hu, Y.-K., Guo, M., Huang, A.-S., Su, X., & Guo, C. (2017) · Chemical Papers · doi:10.1007/s11696-017-0239-z · Cited by 13
Antifungal Agents
Espinel‐Ingroff, A. (2009) · Elsevier eBooks · doi:10.1016/b978-012373944-5.00331-x · Cited by 13
Thermoresponsive cholesteric liquid–crystal systems doped with terpenoids as drug delivery systems for skin applications
Nesterkina, M., Ващенко, О. В., Vashchenko, P. V., Lisetski, L. N., Kravchenko, I., Hirsch, A. K. H., & Lehr, C. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.09.002 · Cited by 12
How do terminal modifications of short designed IIKK peptide amphiphiles affect their antifungal activity and biocompatibility?
Zhang, J., Gong, H., Liao, M., Li, Z., Schweins, R., Penny, J. I., & Lu, J. R. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.09.170 · Cited by 12
Systemic Antifungal Agents
Shoham, S., Groll, A. H., Petraitis, V., & Walsh, T. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00156-8 · Cited by 12
In vitroinvestigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone onCandida albicans
Sigle, H.-C., Schäfer‐Korting, M., Körting, H. C., Hube, B., & Niewerth, M. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01228.x · Cited by 12
Comparative Study on the Efficacy of Liposomal Amphotericin B and Voriconazole in a Murine Pulmonary Aspergillosis Model
Takemoto, K., Yamamoto, Y., Ueda, Y., Kanazawa, K., Yoshida, K., & Niki, Y. (2009) · Chemotherapy · doi:10.1159/000194661 · Cited by 12
Genome-wide Analysis of the Expression Profile of Saccharomyces cerevisiae in Response to Treatment with the Plant Isoflavone, Wighteone, as a Potential Antifungal Agent
Yin, H., Zhao, Y., Zhang, Y., Zhang, H., Xu, L., Zou, Z., Yang, W., Cheng, J., & Zhou, Y. (2005) · Biotechnology Letters · doi:10.1007/s10529-005-4954-0 · Cited by 12
Recommendations for the treatment of fungal pneumonias
Yamada, H., Kotaki, H., & Takahashi, T. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.8.1241 · Cited by 12
Prise en charge des mycoses urinaires
Etienne, M., & Caron, F. (2007) · La Presse Médicale · doi:10.1016/j.lpm.2006.12.033 · Cited by 12
Novel Drug Delivery Systems for Antifungal Compounds
Zia, Q., Farzuddin, M., Ansari, M. A., Alam, M., Ali, A., Ahmad, I., & Owais, M. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_20 · Cited by 11
Invasive Aspergillosis in Children with Hematologic Malignancies
Hasan, R. A., & Abuhammour, W. (2006) · Pediatric Drugs · doi:10.2165/00148581-200608010-00002 · Cited by 11
Comparison of the efficacy of honey gel and clotrimazole cream in the treatment of vaginal candidiasis symptoms: a randomized clinical trial
Seifinadergoli, Z., Nahidi, F., Safaiyan, A., Javadzadeh, Y., & Eteraf-Oskouei, T. (2018) · Electronic physician · doi:10.19082/6904 · Cited by 11
Synthesis and Fungicide Activity onAsperisporium caricaeof Glycerol Derivatives Bearing 1,2,3-Triazole Fragments
lima, Â. M. A., Teixeira, R. R., Moraes, W. B., da Rocha, M. R., Moraes, A. F. C., Gomes, S. C., Gazolla, P. A. R., da Silva, S. F., de Queiroz, V. T., Fonseca, V. R., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c08941 · Cited by 10
Antioxidant, antimicrobial and cytotoxic properties of four different extracts derived from the aerial parts of Chiliadenus iphinoides
Sbieh, R., Al-Lahham, S., & Jaradat, N. A. (2022) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2022.102149 · Cited by 10
Multiple effects of a novel compound fromBurkholderia cepaciaagainstCandida albicans
Li, X., Quan, C., Yu, H., & Fan, S.-D. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01238.x · Cited by 10
The Candida albicans AAA ATPase homologue of Saccharomyces cerevisiae Rix7p (YLL034c) is essential for proper morphology, biofilm formation and activity of secreted aspartyl proteinases.
Melo, A. S. D. A., Padovan, A. C. B., Serafim, R. C., Puzer, L., Carmona, A. K., Juliano, L., Brunstein, A., & Briones, M. R. S. (2006) · PubMed · Cited by 10
Experiences with the use of caspofungin in paediatric patients
Lehrnbecher, T., & Groll, A. H. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01529.x · Cited by 10
Antimicrobial resistance in vulvovaginitis
Sobel, J. D. (2001) · Current Infectious Disease Reports · doi:10.1007/s11908-001-0093-5 · Cited by 10
Acute Infusion-Related Side Effects of Amphotericin B Lipid Complex (ABLC) in Oncohematological Patients: Real-World Data from Brazilian Reference Centers
Cavassin, F. B., Magri, M. M. C., Borgmann, A. V., Floriani, I. D., Barreto, M. R., Zaleski, T., Carlesse, F. A. D. M. C., Breda, G. L., Motta, F. D. A., Falci, D. R., et al. (2024) · Infectious Diseases and Therapy · doi:10.1007/s40121-024-01086-y · Cited by 9
The first case of Acrophialophora levis-induced severe pneumonia: a case report and literature review
Huang, J., & Liu, Z. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4528-8 · Cited by 9
Carbonaceous nanomaterials integrated carbon paste sensors for adsorptive anodic voltammetric determination of butenafine in the presence of its degradation product
Gad, E. M., Hendawy, H. A. M., Fouad, M. A., & Khaled, E. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107956 · Cited by 9
Disposition of amphotericin B in the isolated perfused rat liver
Hong, Y., Ramzan, I. M., & McLachlan, A. J. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022502 · Cited by 9
Multiparametric LC-MS/MS method for simultaneous determination of eleven antifungal drugs and metabolites in human plasma
Bendjilali-Sabiani, J.-J., Constans, C., Mathieu, O., & Cazaubon, Y. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116557 · Cited by 8
Pharmacotherapy of Candida bloodstream infections: new treatment options, new era
Lewis, R. E. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.8.1039 · Cited by 8
Cryptococcal Infections in Children: Retrospective Study and Review from Australia
Grimshaw, A., Palasanthiran, P., Huynh, J., Marais, B. J., Chen, W., & McMullan, B. J. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0215 · Cited by 8
Effect of Local Antifungal Treatment on Nasal Polyposis
Ricchetti, A., Landis, B. N., Giger, R., Zheng, C., & Lacroix, J. (2002) · Oto-Rhino-Laryngologia Nova · doi:10.1159/000070911 · Cited by 8
Bioactivity and Therapeutic Potential of Plant Extracts in Cancer and Infectious Diseases
Fodouop, S. P. C., Simo, R. T., Amvene, J. M., Talla, E., Etet, P. F. S., Takam, P., Kamdje, A. H. N., & Jm, M. (2015) · Journal of Diseases and Medicinal Plants · doi:10.11648/j.jdmp.20150101.12 · Cited by 7
Pharmacokinetics, Safety and Efficacy of Voriconazole in Pediatric Patients: An Update
Dokos, C., Pieper, S., Lehrnbecher, T., & Groll, A. H. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0090-1 · Cited by 7
Antifungal therapy in children: an update
Cecinati, V., Guastadisegni, C., Russo, F. G., & Brescia, L. P. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1758-9 · Cited by 7
Established and Emerging Oral Antifungals in Dermatology
Pierard, G., Piérard-Franchimont, C., Vroome, V., Arrese, J., Quatresooz, P., Borgers, M. J., & Cauwenbergh, G. (2007) · CRC Press eBooks · doi:10.3109/9780849375903-18 · Cited by 7
A subdose of fluconazole alters the virulence ofCryptococcus gattiiduring murine cryptococcosis and modulates type I interferon expression
Fontes, A. C. L., de Oliveira, D. B., Santos, J. R. A., Carneiro, H. C. S., Ribeiro, N. D. Q., Oliveira, L. V. N., Barcellos, V. A., da Paixão, T. A., Abrahão, J. S., de Resende, M. A., et al. (2016) · Medical Mycology · doi:10.1093/mmy/myw056 · Cited by 7
Aspergillus Sinusitis and Cerebral Aspergillosis
Schwartz, S., & Ruhnke, M. (2014) · ASM Press eBooks · doi:10.1128/9781555815523.ch24 · Cited by 7
Efeito de antifúngicos em suspensões e biofilmes de Candida albicans e Candida dubliniensis
Cardoso, B. C. (2004) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 7
Synthesis, Characterization and Antimicrobial Evaluation of Substituted 1,2,4-Triazole Thiones Containing Pyrazole Moiety
PRASAD, A. G. (2014) · The Annals of Clinical and Analytical Medicine · doi:10.4328/jcam.2323 · Cited by 6
Therapeutic drug monitoring for antifungal triazoles: pharmacologic background and current status
Groll, A. H., & Gastine, S. (2019) · Handbook of analytical separations · doi:10.1016/b978-0-444-64066-6.00009-5 · Cited by 7
Antifungal and Antiviral Therapy
Ostrosky-Zeichner, L. L., & Rex, J. H. (2008) · Elsevier eBooks · doi:10.1016/b978-032304841-5.50055-8 · Cited by 6
One Century of Study: What We Learned about Paracoccidioides and How This Pathogen Contributed to Advances in Antifungal Therapy
Kioshima, É. S., Mendonca, P., Teixeira, M. D. M., Capoci, I. R. G., Amaral, A. C., Rodrigues-Vendramini, F. A. V., Simões, B. L., Abadio, A. K. R., Matos, L. F., & Felipe, M. S. S. (2021) · Journal of Fungi · doi:10.3390/jof7020106 · Cited by 7
Managing Intraoral Lesions in Oral Cancer Patients in a General Dental Practice: An Overview
Kim, R. H.-K., Yang, P. G., & SUNG, E. C. (2016) · Journal of the California Dental Association · doi:10.1080/19424396.2016.12220974 · Cited by 6
Pediatric pharmacology of antifungal agents
Groll, A. H., Roilides, E., & Walsh, T. J. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0008-0 · Cited by 6
Emerging opportunistic fungal infections: where are we heading?
Idemyor, V. (2003) · PubMed Central · Cited by 6
Quantitative Method for the Determination of Posaconazole in Mouse Tissues using Liquid Chromatography-Mass Spectrometry
Serafi, I. E. (2014) · Journal of Analytical & Bioanalytical Techniques · doi:10.4172/2155-9872.1000193 · Cited by 5
Therapeutic potential of morpholine-based compounds in neurodegenerative diseases: SAR insights and analysis
Kumar, S., Bishnoi, P., Chauhan, N., Kumar, P., & Aggarwal, R. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2515812 · Cited by 5
Computational analysis of phytocompounds with 1, 3 - β-D-Glucan synthase for antidermatophytic activity
Jeyam, M., Arangaraj, M., Ravikumar, P., & Shalini, G. (2014) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2014.40211 · Cited by 5
Rational design, synthesis, analysis and antifungal activity of novel myristic acid derivatives as N-myristoyltransferase inhibitors
Javid, S., Shanmugarajan, D., Kumar, H. Y., Arivuselvam, R., Anjum, N. F., Purohit, M. N., Susil, A., Harindranath, H., Nilugal, K. C., Nagojappa, N. B. S., et al. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.137568 · Cited by 5
Clinical Pharmacology of Itraconazole in Children and Adolescents
Drogouti, E., Pana, Z. D., Tragiannidis, A., Hempel, G., & Groll, A. H. (2015) · Current Fungal Infection Reports · doi:10.1007/s12281-015-0218-1 · Cited by 5
Antifungal agents
Shoham, S., Groll, A. H., & Walsh, T. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00149-0 · Cited by 6
Prevention and Management of Complications
Kanodia, A., Verma, H., Jain, A., Kalsotra, G., Kumari, S., Agrawal, S. K., Gautam, H., Kaushal, D., Gugliani, A., & Lodha, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-6284-0_8 · Cited by 6
Stereoselective Asymmetric Syntheses of Molecules with a 4,5-Dihydro-1H-[1,2,4]-Triazoline Core Possessing an Acetylated Carbohydrate Appendage: Crystal Structure, Spectroscopy, and Pharmacology
Maqbali, A. S. A., Al‐Rasbi, N. K., Zoghaib, W. M., Sivakumar, N., Robertson, C. C., Shongwe, M. S., Grzegorzek, N., & Abdel-Jalil, R. J. (2024) · Molecules · doi:10.3390/molecules29122839 · Cited by 5
Feohifomicosis cerebral: descripción de un caso y revisión de la literatura
Frasquet, J., Pemán, J., Blanes, M., Hernández-Porto, M., Cano, J., Jiménez-Herrero, E., & López-Hontangas, J. L. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.12.008 · Cited by 5
Azoles and antidepressants: a mini‐review of the tolerability of co‐administration
Roussos, P., Lewis, R. E., & Kontoyiannis, D. P. (2009) · Mycoses · doi:10.1111/j.1439-0507.2008.01677.x · Cited by 5
Systemic Antifungal Agents
Lewis, R. E., & Wiederhold, N. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-35803-6_8 · Cited by 5
Infektionen
Groll, A. H., Simon, A., & Lehrnbecher, T. (2005) · Springer eBooks · doi:10.1007/3-540-29036-2_79 · Cited by 4
Antifungal drugs
Groll, A. H., Chiou, C. C., & Walsh, T. J. (2001) · Side effects of drugs annual · doi:10.1016/s0378-6080(01)80032-5 · Cited by 4
Acrophialophora: A Comprehensive Review of Clinical Guidelines and Diagnosis
Bhattaru, A., Blanchard, I., Kunamneni, S., Rojulpote, C., Iskander, P., Nasr, S., & Klamp, D. (2023) · Cureus · doi:10.7759/cureus.37614 · Cited by 4
Evolution of antimicrobial drug resistance in human pathogenic fungi
Mir, M. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00009-7 · Cited by 4
Pharmacology of azole antifungal agents
Ashley, E. S. D. (2019) · CRC Press eBooks · doi:10.1201/9780429402012-12 · Cited by 4
Mucocutaneous and Deeply Invasive Candidiasis
Shoham, S., Nucci, M., & Walsh, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00088-4 · Cited by 4
Case report of cerebral phaeohyphomycosis caused by Fonsecaea monophora
Stokes, W., Fuller, J., Meier‐Stephenson, V., Remington, L. T., & Meatherall, B. L. (2017) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.2.1.013 · Cited by 4
Fungal infections in pediatric patients
Groll, A. H., Roilides, E., & Walsh, T. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00022-0 · Cited by 4
Echinocandins
Groll, A. H., Schrey, D., & Walsh, T. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_6 · Cited by 4
Characterization and biological activity of antifungal compounds present in Breonadia salicina (Rubiaceae) leaves
Mahlo, S. M. (2010) · UpSpace Institutional Repository (University of Pretoria) · Cited by 4
Antifungal Drugs
Richardson, F. M. D., & Warnock, F. D. W. (2003) · Wiley eBooks · doi:10.1002/9780470755259.ch3 · Cited by 4
Antifungal Drugs
Seyedmousavi, S. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc295 · Cited by 4
Synergistic Interaction of Certain Essential Oils and Their Active Compounds with Fluconazole against Azole-resistant Strains of Cryptococcus neoformans
Khan, M. S. (2024) · Annals of African Medicine · doi:10.4103/aam.aam_197_23 · Cited by 6
Resistance to Antifungal Drugs
Sanglard, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_9 · Cited by 3
Topical Film Forming Clotrimazole Emulgel
Kathpalia, H., Venkatesh, A., & Sathe, N. (2023) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.57.2s.29 · Cited by 3
Medical Therapy for Fungal Rhinosinusitis
Khattar, V. S., & Hathiram, B. T. (2009) · Otorhinolaryngology Clinics - An International Journal · doi:10.5005/jp-journals-10003-1009 · Cited by 3
Polyene Antifungal Agents
Lewis, R. E. (2009) · Springer eBooks · doi:10.1007/978-90-481-2408-4_17 · Cited by 3
Update on Amphotericin B Pharmacology and Dosing for Common Systemic Mycoses
Lewis, R. E., & Viale, P. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0107-9 · Cited by 3
Prise en charge des mycoses urinaires
Étienne, M., & Caron, F. (2007) · Springer eBooks · doi:10.1007/978-2-287-48617-3_13 · Cited by 3
Efficacy and safety of antifungals in pediatric patients
Groll, A. H. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2011.01.016 · Cited by 3
Composition, in vitro Anti-mildew Fungal Activities of the Heartwood Essential Oil of Chamaecyparis formosensis from Taiwan
Su, Y., Hsu, K.-P., & Ho, C. (2018) · Natural Product Communications · doi:10.1177/1934578x1801301032 · Cited by 3
Pharmacology of Azole Antifungal Agents
Ashley, E. D. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-13 · Cited by 3
Synthetic Studies on Antifungal Peptidyl Nucleoside Antibiotics
Datta, A. (2013) · Wiley eBooks · doi:10.1002/9781118498088.ch18 · Cited by 3
Pharmacological agents in development for invasive aspergillosis
Meis, J. F. G. M., & Ruijgrok, E. J. (2002) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.7.1.33 · Cited by 3
Treatment of invasive aspergillosis in children with hematologic malignancies
Abuhammour, W., & Hasan, R. A. (2004) · The Indian Journal of Pediatrics · doi:10.1007/bf02730724 · Cited by 3
Infektionskrankheiten
Schmitt, H. J., Hauer, T., Daschner, F. D., Hufnagel, M., Scholz, H., Jüngst, B.-K., Huppertz, H., Keller, K., Christen, H. ‐., Eiffert, H., et al. (2001) · Springer eBooks · doi:10.1007/978-3-662-12660-8_14 · Cited by 3
Phytochemical and in Vitro Anti-Microbial Screening of Echinops Hispidus Fresen. and Grewia Similis K. Schum.
Muithya, J. N. (2013) · Kenyatta University Institutional Repository (Kenyatta University) · Cited by 3
Therapy of Invasive Aspergillosis: Current Consensus and Controversies
Kontoyiannis, D. P., & Marr, K. A. (2014) · ASM Press eBooks · doi:10.1128/9781555815523.ch37 · Cited by 2
Antifungal Agents
Lewis, R. E., & Fothergill, A. W. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-325-7_6 · Cited by 2
Effects of Different Concentrations of AmB on the Unsaturated Phospholipid–Cholesterol Membrane Using the Langmuir Monolayer and Liposome Models
Wang, J., Wang, J., Zheng, M., & Li, D. (2024) · Molecules · doi:10.3390/molecules29235659 · Cited by 2
Antifungal Therapy in Pediatric Patients
Lehrnbecher, T., Bochennek, K., Schrey, D., & Groll, A. H. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0046-x · Cited by 2
Antifungal Agents in Current Pediatric Practice
Cecinati, V., Perillo, T., Brescia, L. P., & Russo, F. G. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0337-1 · Cited by 2
Application of combination bubble liposomal amphotericin B and sonication has the dramatic effect on oral candidiasis
Yamamoto, M., Iwanaga, K., Okinaga, T., Ariyoshi, W., Tominaga, K., & Nishihara, T. (2017) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2016.11.004 · Cited by 2
Human Fungal Pathogens and Drug Resistance Against Azole Drugs
Bhetariya, P. J., Sharma, N., Singh, P., Tripathi, P., Upadhyay, S. K., & Gautam, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_18 · Cited by 3
Comparison of the Efficacy of Honey Gel and Clotrimazole Cream in the Treatment of Vaginal Candidiasis Signs: A Randomized Clinical Trial
Seifinadergoli, Z., Nahidi, F., Safaiyan, A., Javadzadeh, Y., & Eteraf-Oskouei, T. (2020) · Journal of Caring Sciences · doi:10.34172/jcs.2020.024 · Cited by 2
Cerebral Aspergillus Infections and Meningitis
Schwartz, S. (2009) · Springer eBooks · doi:10.1007/978-90-481-2408-4_48 · Cited by 2
Antifungal Drugs
Bustamante, B., Hidalgo, J. A. M., & Campos, P. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-64113-3_2 · Cited by 2

Authors: Groll, A. H., Piscitelli, S. C., & Walsh, T. J.
Affiliations: National Institutes of Health (US)
ORCID: Groll, Andreas H.
Piscitelli, Stephen C.
Walsh, Thomas J.
Venue: Advances in pharmacology
Publisher: Elsevier
Published: 1998
Volume: 44
Pages: 343-500
ISSN: 1054-3589 (ISSN-L)
DOI: 10.1016/s1054-3589(08)60129-5
OpenAlex: W63281979
Cited by: 377
References: 930
Citations by year: 2026: 3 · 2025: 3 · 2024: 16 · 2023: 7 · 2022: 12 · 2021: 8 · 2020: 13 · 2019: 7 · 2018: 8 · 2017: 10 · 2016: 13 · 2015: 13 · 2014: 16 · 2013: 13 · 2012: 7
FWCI: 54.29
Type: book chapter
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advances in pharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords: systemic antifungal agents, clinical pharmacology, antifungal drug development, antifungal drug targets, fungal infection
MeSH terms: Animals, Antifungal Agents, Fungi, Humans, Mycoses, Triazoles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks